The abstract is read at the publisher; the summary is JClub's.
In Senegalese Plasmodium falciparum infections (2006–2022), resistance-associated alleles predominated, and specific haplotypes drove large EC50 shifts and fitness trade-offs.
- Why it matters: Antimalarial drug resistance threatens malaria control, and Senegal’s long-running chemoprevention and treatment policies likely select evolving parasite genotypes with consequences for drug response and parasite fitness.
- What they did: Whole-genome sequencing from 2,805 monogenomic infections across Senegal was paired with in vitro culture of 33 clinical isolates spanning 26 common combined haplotypes (63.9% of WGS infections), followed by mixed-effects EC50 modeling and competitive growth assays.
- The result: Compared with Pfcrt WT, CVIET increased monodesethyl-amodiaquine EC50 ~1.4-fold and adding N326S or I356T increased it ~2.6-fold and ~3.2-fold; Pfdhfr triple mutant raised pyrimethamine EC50 ~2,196-fold, and Pfdhps A437G raised sulfadoxine EC50 ~463,000-fold, alongside genotype-linked competitive ability changes.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.